Skip to main content
letter
. 2020 Jun 30;160:105053. doi: 10.1016/j.phrs.2020.105053

Fig. 1.

Fig. 1

Forest plot of re-estimated ACEI/ARB exposure and risk of mortality in (A) Covid-19 patients and (B) Covid-19 patients with antihypertensive indication.